Please Fill Up Your Company Details And Your Designation

Update Your Profile
 
Your email ID :  
     
Password :  
     
          
New user? Create an account               Forgot password?
     
 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Industrial Products India, Industrial Manufacturers & Suppliers
 




 
   
 
 
 

Domestic Pharma Growth Improves

Domestic Pharma Growth Improves for the month of May

 Sequentially, the domestic pharma industry staged an improvement for the month of May. According to data compiled by PharmaTrac, at 9.9%, the growth is best in the year 2013. 

There was an improvement of growth in case of the anti-infectives segment, being the largest category in the Indian pharmaceutical market constituting nearly 18% of the industry revenues. From therapy perspective 9 therapies have outgrown the IPM growth. Respiratory market grew at 10.4%, anti-diabetic market increased 12.5% and cardiac at 12.9% in chronic business. Amongst top 10 therapies, Neuro/CNS market grew the highest at 13.2%. 

Amongst the top 10 companies, Zydus group of companies grew at 24.3%, Sun Pharma at 21.2%, & Ranbaxy registered growth of 20.2%. 

 
     
 
   
      More...
 
 
 
     
 
 
     


 
 
FORUM  
Are Indian Brands
Globally competitive
    
   
 
 
 
 
     
   
More >>